Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

BACKGROUND: In this paper, we report the health related quality of life (HRQOL) data from patients with hepatitis C viral infection (HCV) who were refractory to prior therapy and had re-treatment with a combination of Pegylated interferon alpha-2b and ribavirin. We hypothesized that the HRQOL will i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Abraham, Peiffer, Laurie P, Rhoades, Kathy, McGarrity, Thomas J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479317/
https://www.ncbi.nlm.nih.gov/pubmed/16696859
http://dx.doi.org/10.1186/1477-7525-4-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479317/
https://www.ncbi.nlm.nih.gov/pubmed/16696859
http://dx.doi.org/10.1186/1477-7525-4-30

Ejemplares similares